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Abstract
Objective: Tumours are commonly hypoxic and this can be associated with aggressive tumour type, metastasis and
resistance to therapy. Heat shock proteins (hsps) are induced in response to hypoxia, provide cancer cells with protection
against tumour-associated stressors and chaperone oncoproteins that drive tumour proliferation. This study examined the
effect of different oxygen concentrations on the expression of hsps in melanoma cell lines.
Methods: Melanoma cell lines were cultured in 2% and 20% O2. Expression of Hsp90, Hsp70, Hsp60, Hsp40 and Hsp32
proteins were determined by flow cytometry.
Results: Growth rates and viability were reduced in the majority of cell lines by culture in 2% O2. Hsp expression was
different in 2% compared to 20% O2 and changes in Hsp90 expression correlated with cell line generation time (P,0.005)
and viability (P,0.01). Greater total hsp expression correlated with improved viability in 2% but not 20% O2 (P,0.05).
Relative expression of the different hsps was consistent across cell lines and each correlated with the others (P=0.0001) but
not with Hsp32. Hsp expression was inversely correlated with cell line adhesion to laminin as well as collagen type IV and
Breslow depth of the original primary tumour tissue (P,0.05), but not with Clark level or patient survival. All five hsps were
identified on the cell surface.
Conclusion: Culture in 2% O2 variably altered hsp expression in a panel of melanoma cell lines. Hsp expression was
associated with certain cell line characteristics and clinical parameters of the originating tumour.
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Introduction
It is well established that hypoxia is a feature of human tumours
[1,2,3].Thehypoxicstateistheresultofthecombinedeffectsofrapid
proliferation of malignant cells and abnormal behaviour of blood
vessels, resulting in insufficient blood supply to the tumour mass
[1,2,3,4]. Hypoxia contributes to the biology of tumours through




therapy, moreaggressive tumours, tumourinvasion,poor prognosis
and patient death [5,8,10,11]. Despite typically being a relatively
small tumourfrequently found ontheskin, hypoxiaisnevertheless a
feature of human melanoma [1,12,13]. In melanoma, hypoxia is
associated with tumour metastasis and may serve to enhance
metastatic spread [14,15,16,17].
The major mechanism by which cells respond to hypoxic stress
is by rapid modulation of the expression of the HIF transcription
factor [18]. HIF directly regulates the expression of heat shock
proteins (hsps) and heat shock protein 90 (Hsp90) has been shown
to assist in the stabilisation of HIF under hypoxic conditions in
melanoma cells [19,20]. Other studies suggest Hsp90 is involved in
HIF expression and transactivation under hypoxia [21]. Hsps are
an essential group of proteins that function as molecular
chaperones and play a multitude of roles in eukaryotic cells [22].
Many of their functions contribute to the survival of tumour cells;
accordingly, hsps have been shown to be abnormally expressed in
a range of human cancers [23]. They promote the growth of
cancer cells through multiple mechanisms such as inhibiting
apoptosis, enhancing angiogenesis and providing protection
against tumour-associated stressors such as hypoxia
[23,24,25,26,27]. Hsps perform these roles in addition to
chaperoning overexpressed oncoproteins that drive the prolifera-
tion of tumour cells [23,28]. Consequently, hsps have been
identified as valid targets in the treatment of cancer and are
currently being evaluated in clinical trials in a number of cancer
types including melanoma [29]. Hsp expression has been shown to
be important in melanoma and relevant to patient clinical
parameters such as Breslow depth, Clark level and survival
[30,31,32,33].
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documented, but has rarely been studied in the context of human
cancer cell cultures. Laboratory cell culture is routinely performed
under hyperoxic conditions (i.e. in air) and this may be a limitation
of this model for the study of human cancer cells which frequently
experience hypoxia in vivo. Hsps have been investigated in
melanoma tumour tissue and play multiple roles important for
cancer growth, but have not been extensively studied in melanoma
cell lines. Here, we present a preliminary study that sought to
assess hsp expression in relation to melanoma cell line character-
istics, patient clinical parameters and low and high oxygen culture
conditions in a relatively large panel of melanoma cell lines.
Methods
Cell lines: Melanoma cell lines were selected from the European
Searchable Tumour Line Database (ESTDAB; http://www.
medizin.uni-tuebingen.de/estdab/) which is the largest existing
collection of melanoma cell lines. The ESTDAB cell lines have
been thoroughly characterised and controlled with mycoplasma
testing and DNA finger printing [34]. The sample cohort used in
this study consisted of 40 cell lines of metastatic tumour origin and
two of primary tumour origin (EST 66 and 83). For a full list of the
cell lines used, see Fig. 3.
Cell culture: Cell lines were cultured with 35 ml RPMI 1640
medium (Life Technologies, Darmstadt, Germany) supplemented
with 10% heat inactivated Foetal Calf Serum (FCS) (Sigma,
Munich, Germany) in 75 cm
2 cell culture flasks (Greiner Bio-One,
Frickenhausen, Germany) for five days in an incubator (37uC, 5%
CO2, 95% humidity) in air (20% O2) and in 2% O2 using the
Concept 1000 Invivo2 (Ruskinn Technology, Pencoed, UK).
Seeding cell number was adjusted according to the generation
time (time required for one population doubling) of each cell line
in order to avoid confluence and to obtain similar cell numbers at
the end of the culture period. Following the culture period cells
were washed with Hank’s Buffered Salt Solution (HBSS) (PAA,
Pasching, Austria) and detached from culture flasks by incubation
with Trypsin-EDTA (Cambrex, Wiesbaden, Germany) (200 mg/l
EDTA, 500 mg/l Trypsin 1:250) for approximately three minutes.
Trypsin was inactivated by adding of an equal volume of RPMI
medium containing 10% FCS.
Determination of cell number and viability: The trypan blue
exclusion method was used to determine the number of living and
dead cells. Melanoma cells were suspended in 10 ml of HBSS and
mixed thoroughly. Equal volumes of a 0.4% trypan blue solution
(Sigma) and the cell sample were mixed and applied to a Neubauer
haemocytometer. Phase contrast microscopy was used to distin-
guish between stained (dead) and unstained (living) cells.
Flow cytometry: Following trypsinisation, 3.0610
5 cells were
washed with PFEA (phosphate buffered saline, 2% FCS, 2 mM
EDTA, and 0.01% azide) and Fc receptors blocked with
GAMUNEX (Bayer, Leverkusen, Germany) on ice for ten
minutes. Cells were washed with PFEA before being permeablised
and fixed with Cytofix/Cytoperm and Perm/Wash (BD Biosci-
ences, Heidelberg, Germany) according to the manufacturer’s
instructions. Single fluorochrome staining was performed where
antibody was diluted in Perm/Wash and incubated for 30 minutes
on ice. PE-conjugated antibodies were used at the following
concentrations: Hsp90 1:300 (product #SPA-830PE), Hsp70
1:100 (product #SPA-820PE), Hsp60 1:100 (product #SPA-
807PE), Hsp40 1:100 (product #SPA-400PEF), Hsp32 1:100
(product #OSA-111PE) (all from Enzo Life Sciences, Lo ¨rrach,
Germany). Following incubation cells were washed twice with
Perm/Wash before being suspended in 120 mL of 1% formalde-
Figure 1. Effectoflowoxygencultureonmelanomacelllinegenerationtimeandviability.Eighteenmelanomacelllineswereculturedunder
identicalconditionsin2%and20%O2forfivedays.Followingthecultureperiod,thecelllineswereharvestedandlivinganddeadcellsenumeratedusing
trypanblue.Totalnumberof livingcellswas usedtocalculategenerationtime,andratioof liveto deadcellswas usedas amarkerof cellviability.
doi:10.1371/journal.pone.0037475.g001
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on ice in a darkened container. For cell surface staining, PFEA was
used in place of Cytofix/Cytoperm and Perm/Wash. Cells were
immediately analysed on an LSR II flow cytometer with
FACSDiva software (BD Biosciences). Data was analysed using
FlowJo software (Tree Star, Ashland, USA). To perform data
analysis, the main population of cells was gated on a forward
scatter versus side scatter dot plot according to size and
granularity. For each sample a fluorescence index (FI) was
calculated in order to allow the comparison of fluorescence values
for each cell line. The FI is the fold increase of the mean
fluorescence intensity of the main population of cells in the stained
cell sample by comparison with the corresponding unstained
sample. FI values of less than two were considered negative.
Statistical analysis: Statistical analysis was performed using
Prism software version 4.02 (GraphPad, San Diego, USA). Cell
line ligand adhesion data was obtained from ESTDAB. Within
matching data sets, changes of less than 5.0% were not considered
to be different.
Paired two-tailed non-parametric t tests (Wilcoxon matched
pairs tests) were used to assess significance between matching data
points between two conditions.
Significance between two groups was assessed with two-tailed
non-parametric (Mann-Whitney U) tests.
Correlations were assessed with non-parametric two-tailed
(Spearman) correlation tests.
Trends across four grouping variables were assessed with two-
tailed chi-squared contingency tests.
Results
Low Oxygen Tension Reduces Viability and Retards
Growth in the Majority of Melanoma Cell Lines
Eighteen melanoma cell lines were selected for culture in 2%
O2. Twelve of 18 cell lines showed a mean increase of 70% in
generation time when cultured in 2% O2 compared with the 20%
O2 condition (P=0.054). Five of the remaining six cell lines
showed reduced generation times (mean decrease 26%), while the
remaining cell line did not change (Fig. 1 A). Cell viability was
accordingly reduced in 11 of 17 cell lines (P=0.096), while four
showed improved viability and two did not change (Fig. 1 B) (no
data for 1 cell line). Four of the five cell lines that showed faster
generation times in the 2% O2 condition also displayed improved
viability in 2% O2 (EST 174, 194, 196 and 207), while one cell line
showed no change for both generation time and viability (EST
143).
Low Oxygen Tension Results in Differential Heat Shock
Protein Expression
Comparing hsp expression between the 2% and 20% O2
conditions showed that low oxygen culture resulted in up- or
down-regulation of hsp expression (Table 1). For each of the four
hsps examined, approximately half of the cell lines showed
decreased expression in the 2% O2, while a smaller proportion
showed increases. Six cell lines showed a reduction in the
expression of all four hsps in the 2% O2 condition (EST 66, 76,
105, 108, 138 and 153), but the remaining cell lines up- and down-
regulated these four hsps in response to low oxygen tension. Of
note is that the four cell lines that showed faster generation times
and improved viability in the 2% O2 condition showed a
corresponding increase in Hsp90 expression in the 2% O2 culture
condition.
Heat shock Protein Expression is Associated with
Melanoma Cell Line Generation Time and Viability
Because low oxygen tension resulted in altered hsp expression
and influenced generation time and viability in these cell lines, the
association of hsp expression with generation time and viability
was investigated in the 2% and 20% O2 culture conditions. With
the exception of Hsp60 in 20% O2 (P,0.03), total hsp expression
was not associated with generation time in either condition (data
not shown). When examining the increase or decrease in hsp
expression in response to low oxygen tension, associations between
the change in Hsp90 expression with cell line generation time
(P,0.005, Table 2) were observed, but not for the other hsps (data
not shown).
The relationship between hsp expression and viability in the 2%
and 20% O2 culture conditions was then assessed. Significant
relationships were found between higher expression of Hsp90,
Hsp70 and Hsp60 and improved cell viability in the 2% (P,0.05)
but not in the 20% O2 culture condition (Fig. 2). Examining the
change in hsp expression between the 2% and 20% O2 culture
Table 1. Change in hsp expression in response to low oxygen tension.
Hsp
Decrease of hsp expression
in 2% O2 (% of cell lines) Mean decrease (%)
Increase of hsp expression
in 2% O2 (% of cell lines) Mean increase (%)
90 50.0 19.5 38.9 13.9
70 44.4 27.3 44.4 15.0
60 50.0 20.4 33.3 16.8
40 61.1 18.3 16.7 16.8
Eighteen melanoma cell lines were cultured under identical conditions in 2% and 20% O2. After five days the cell lines were harvested, stained with PE-conjugated hsp
antibodies and protein expression assessed by flow cytometry. A Fluorescence Index was calculated (fold increase in mean fluorescence of the stained cells compared
with the unstained cells) and was used as a comparative measure of protein expression.
doi:10.1371/journal.pone.0037475.t001
Table 2. Association between change in Hsp90 expression





Decreased generation time in 2% 0 5
Increased generation time in 2% 8 2
P,0.005.
Changes in cell line generation time were correlated with changes in Hsp90
expression between the 2% and 20% O2 culture conditions.
doi:10.1371/journal.pone.0037475.t002
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PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e37475Figure 2. Effect of low oxygen culture on hsp expression. Forty two melanoma cell lines were cultured in 20% O2 and 18 of these cell lines
additionally in 2% O2 for five days. Following the culture period, the cell lines were harvested and the number of living and dead cells determined
using trypan blue. The ratio of live to dead cells was used as a marker of cell viability.
doi:10.1371/journal.pone.0037475.g002
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associated with cell line viability (P,0.01, Table 3).
The Expression of the Different Heat Shock Proteins
Correlates with one Another and with Melanoma Cell
Line Adhesion
Hsp expression was compared throughout the cohort of
melanoma cell lines cultured in 20% O2 (Fig. 3). Hsp90 was
observed to account for the vast majority of total hsp expression in
every cell line. The next most abundantly expressed hsps were
Hsp40 and Hsp70, while Hsps 60 and 32 were similarly expressed
at relatively low levels.
Given that the relative expression of hsps was observed to be
consistent, relationships between the expression of these hsps were
investigated. The expression of Hsp90, Hsp70, Hsp60 and Hsp40
was found to correlate, but not Hsp32 (in 2% (P=0.015) and 20%
O2 (P=0.0001)) (Fig. 4, Hsp32 not tested in 2% O2).
Hsp90 is involved in cell adhesion [35] and for this reason a
relationship between Hsp90 expression and adhesion to collagen
type IV, fibronectin and laminin was investigated. An inverse
correlation was found between the expression of Hsp90 and
adhesion to these ligands (Fig. 5).
Heat Shock Protein Expression Correlates with Breslow
Depth but not Clark Level or Patient Survival
The expression of hsps in melanoma tissue has been shown to
correlate with clinical parameters, but few, if any, studies have
been performed on hsp expression in melanoma cell lines in this
context. Patient survival time, Clark level and Breslow depth of the
primary tumour tissue was known for a limited number of the
metastasis-derived cell lines in the biobank used here, and were
tested for a correlation with the expression of hsps. The expression
of Hsp90 and Hsp40 was found to inversely correlate with Breslow
depth, but no relationships were found with patient survival or
Clark level (Fig. 6, Clark level data not shown).
Hsps are Located on the Surface of Melanoma Cells as
Well as Intracellularly
Cancer cells have previously been reported to express hsps on
the cell surface and for this reason ten melanoma cell lines were
screened for expression of cell surface hsps (Fig. 7). Hsps 90, 70,
60, 40 and 32 were observed to be expressed on all ten cell lines
with the exception of three cell lines being negative for Hsp32
(EST 83, 108, 152) while one was negative for Hsp90 (EST 108).
In comparison to intracellular expression, cell surface hsp
expression was low. Of note is that Hsp90 was not the most
highly expressed hsp on the cell surface, in contrast to its
intracellular expression level. The expression of cell surface hsps
did not correlate with intracellular hsp expression (P.0.35) (data
not shown).
Table 3. Association between change in Hsp90 expression





Decreased viability in 2% 7 2
Increased viability in 2% 0 4
P,0.01.
Changes in cell line viability were correlated with changes in Hsp90 expression
between the 2% and 20% O2 culture conditions.
doi:10.1371/journal.pone.0037475.t003
Figure 3. Hsp expression across melanoma cell lines. Forty two melanoma cell lines were cultured 20% O2 for five days. Following the culture
period cell lines were harvested, stained with PE-conjugated antibodies to Hsps 90, 70, 60, 40 and 32 and protein expression assessed by flow
cytometry. A Fluorescence Index was calculated (fold increase in mean fluorescence of the stained cells compared with the unstained cells) and was
used as a comparative measure of protein expression across the cell lines.
doi:10.1371/journal.pone.0037475.g003
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PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e37475Figure 4. Correlation between the expression of different hsps. Melanoma cell lines were cultured in 2% O2 and 20% O2 for five days.
Following the culture period cell lines were harvested, stained with PE-conjugated antibodies to Hsps 90, 70, 60, 40 and 32 and protein expression
assessed by flow cytometry.
doi:10.1371/journal.pone.0037475.g004
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Cancer cell lines are widely used models in cancer studies, but
standard practice dictates culture under hyperoxic conditions (i.e.
in air). Since hypoxia is a common and important feature of
cancer, culture of these cells under high oxygen conditions may
contribute to the generation of misleading results. For this reason
we investigated viability, generation time and hsp expression in
order to assess melanoma cell line response to low oxygen tension.
Although hypoxia is a feature of human melanoma, the majority
of the cell lines tested here displayed retarded growth and reduced
viability under low oxygen conditions. This may be due to the fact
that they have been generated and cultured under hyperoxic
conditions which have prevented the selection of hypoxia-resistant
cells that would normally occur [36]. Hypoxia is a known inducer
of the hsp response, but to the best our knowledge, no studies have
examined the effect of low oxygen on hsp expression in melanoma
or indeed in any other cancer cell lines in the manner performed
here [37]. Unexpectedly, a widespread induction of hsp expression
did not occur in response to low oxygen tension. Despite this,
changes in Hsp90 expression were associated with tolerance to low
oxygen as measured by generation time and viability. These data
suggest that improved hypoxic tolerance is associated with the
induction of hsps in melanoma cells. Further, higher total hsp
expression was associated with improved viability in low but not
high oxygen conditions, perhaps reflecting the anti-apoptotic role
that hsps play in cancer [24,38]. The greater demand placed on
the hsp chaperone system under low oxygen stress when the level
of hsp expression is more likely to be below the threshold required
for cellular survival may account for the observation that hsp
expression was not associated with viability under high oxygen
levels. If these observations are at all reflective of in vivo conditions
then it follows that anti-neoplastic hsp inhibiting drugs may be
relatively more effective in hypoxic tumours in which a range of
standard therapies are known to be less effective [5]. Indeed,
previous reports have shown that melanoma cells require hsps in
order to proliferate [39,40]. Thus, in vivo under hypoxic conditions
their effectiveness may be enhanced. Models that allow regions of
variable oxygen concentration, such as three dimensional culture
models or in vivo xenografts, could be used to confirm or refute the
results presented in this study.
Relative hsp expression was observed to be consistent across the
cohort of cell lines and levels of Hsp 90, 70, 60 and 40 expression
were shown to correlate with one another but not with Hsp32.
Hsp90 is essential for eukaryotic cell viability and it chaperones a
large number of overexpressed client proteins in cancer. This may
explain why Hsp90 was expressed at a level many fold greater than
the other hsps examined [22,41]. However hsps most often
function in coordination with other molecular chaperones [22,42].
The other hsps examined in this study are major Hsp90 co-
chaperones, consistent with the notion that hsps cooperate closely
in their role as molecular chaperones [22]. The intimacy of their
association may explain the observation that their expression
correlated with one another but not with Hsp32, because this
protein is not a molecular chaperone and its function is less related
to that of the other hsps [43].
Hsp expression was observed to correlate with Breslow depth
but not Clark level or patient survival. Studies using primary
melanoma tissue have shown increased Hsp90 expression to be
associated with greater Breslow depth and Clark level [33], but in
the present study with metastatic melanoma cell lines an inverse
relationship was observed. This relationship was observed even
though these lines have been cultured for several generations
under in vitro conditions. Similar reports exist in other contexts
[44]. For example, Walter et al. demonstrated MMP-2 mRNA
levels in renal cancer cell lines to inversely correlate with patient
survival [45]. A potential disadvantage of using cultured cells as
models for in vivo processes is that it is not known how reflective the
parameters measured under these conditions are of in vivo
conditions. The data presented here coupled with at least one
previous report may suggest that cancer cell lines maintain a
degree of relevance to patient clinical parameters and thus may be
of use as models for cancer. This relevance may be maintained
indirectly, since results from previous studies using melanoma
tissue suggest that in contrast to the results of this study using cell
lines, that Breslow depth is positively associated with hsp
expression. Since in these cell lines hsp expression was relevant
to viability in 2% but not 20% O2, culture under low oxygen
tension may be more relevant to in vivo growth conditions, but
further studies are needed to confirm these preliminary findings.
Of note is that the inverse relationship between hsp expression and
Breslow depth was observed in 20% O2, and it is not known if hsp
expression in 2% O2 also correlates with Breslow depth. No
remarkable differences were observed between the primary-
derived and metastasis-derived cell lines in this study.
It should be noted that the observation of an inverse correlation
between hsp expression and Breslow depth does not imply that this
relationship is present in tumours in vivo, as the level of hsp
expression observed in these cell lines may not be reflective of the
level in vivo. This could be due to the influence of the artificial cell
culture environment. Follow-up studies in tumours and cell lines
will confirm or refute the preliminary findings presented here. If
this observation is confirmed, further studies could examine other
clinical and biological features such as the expression of
inflammatory cytokines, tumour ulceration, regional differences
Figure 5. Correlation between Hsp90 expression and cell line ligand adhesion. Hsp expression was tested for correlation with the adhesion
ability of these cell lines to the collagen type IV, fibronectin and laminin ligands.
doi:10.1371/journal.pone.0037475.g005
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melanoma patient clinical parameters.
doi:10.1371/journal.pone.0037475.g006
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invasive front, necrotic core or blood vessels), histological sub-type
or other factors that may interact with or separately explain this
observation. If the level of hsp expression observed in this study is
reflective of in vivo expression, then studies using melanoma tissue
that have shown higher hsp expression to be associated with
greater Breslow depth [33] contradicts the observations here that
higher hsp expression correlates with reduced Breslow depth. This
contradiction might be explained by hsps influencing the
immunogenicity of these cells, producing a more effective immune
response and a smaller resultant tumour [46,47]. Supporting this is
a study in which expression of Hsp70 was found to correlate with
improved survival in melanoma patients [31]. Further, immune
recognition is a potential function for the hsps identified on the cell
surface as membrane-located hsps have been shown to act as
targets for T cells and NK cells [48,49]. The finding here that
Hsp90 and Hsp70 are expressed on the surface of melanoma cells
confirms previous studies, but to the best of our knowledge the
expression of Hsp60, Hsp40 or Hsp32 has not previously been
reported [50,51].
Although this investigation is not an extensive study into the
effects of low oxygen tension on cancer cell cultures, it does present
novel findings with respect to the potential role of hsps and
demonstrates that further investigation into the effects of oxygen
tension on cancer cell cultures is warranted. These data suggest
that hsps associate closely in melanoma cells and that their
expression is associated with tolerance to low oxygen tension and
patient clinical parameters. The in vivo importance of hypoxia
coupled with the finding that hsp expression is relevant to
melanoma cell viability in low but not high oxygen tension
suggests cancer cell cultures should more frequently be subjected
to oxygen tension that more closely resembles in vivo levels in order
to cast more light on the largely unknown influence that this
condition has on the myriad of facets investigated in modern
cancer research.
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